Marco Londei
Geen lopende functies
Loopbaan van Marco Londei
Eerdere bekende functies van Marco Londei
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ANAPTYSBIO, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2016 | 25-03-2020 |
| Corporate Officer/Principal | 20-10-2014 | 01-10-2016 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-11-2012 | 01-09-2014 |
| Imperial College London | Corporate Officer/Principal | 01-07-1999 | 01-07-2013 |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-10-2005 | 01-10-2012 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-10-2005 | 01-08-2008 |
| University College London | Corporate Officer/Principal | 01-07-2003 | 01-09-2007 |
Opleiding van Marco Londei
| Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 3 |
| Italië | 2 |
Operationeel
| Corporate Officer/Principal | 6 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Beurs
- Insiders
- Marco Londei
- Ervaring
